• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Recent advances in pancreatic cancer: updates and insights from the 2015 annual meeting of the American Society of Clinical Oncology.胰腺癌的最新进展：来自2015年美国临床肿瘤学会年会的更新与见解
Therap Adv Gastroenterol. 2016 Mar;9(2):141-51. doi: 10.1177/1756283X15622601.
2
The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report.第 34 届韩国妇科肿瘤学会年会 2019 年会议报告。
J Gynecol Oncol. 2019 Jul;30(4):e91. doi: 10.3802/jgo.2019.30.e91.
3
Advances in brain metastases presented at the American Society of Clinical Oncology 2016 Annual Meeting: Part I.在美国临床肿瘤学会2016年年会展示的脑转移瘤研究进展：第一部分。
Future Oncol. 2016 Nov;12(22):2535-2538. doi: 10.2217/fon-2016-0341. Epub 2016 Sep 5.
4
American Society of Clinical Oncology 2021 Annual Meeting updates on primary brain tumors and CNS metastatic tumors.美国临床肿瘤学会 2021 年年会关于原发性脑肿瘤和中枢神经系统转移瘤的更新。
Future Oncol. 2021 Nov;17(33):4425-4429. doi: 10.2217/fon-2021-0955. Epub 2021 Oct 21.
5
Advances in brain metastases presented at the American Society of Clinical Oncology 2016 Annual Meeting: Part II.美国临床肿瘤学会 2016 年年会中提出的脑转移瘤的最新进展：第二部分。
Future Oncol. 2016 Dec;12(23):2669-2672. doi: 10.2217/fon-2016-0378. Epub 2016 Sep 8.
6
Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.局部晚期胰腺癌的最新进展。“2010年美国临床肿瘤学会年会”亮点。美国伊利诺伊州芝加哥。2010年6月4日至8日。
JOP. 2010 Jul 5;11(4):313-6.
7
Meeting report: Current cancer perspectives from the 9 Annual Meeting of the Japanese Society of Medical Oncology.会议报告：日本医学肿瘤学会第9届年会的当前癌症观点
Thorac Cancer. 2012 Feb;3(1):94-97. doi: 10.1111/j.1759-7714.2011.00076.x.
8
Updates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.吉西他滨难治性胰腺腺癌的治疗进展。“2011年美国临床肿瘤学会年会”亮点。美国伊利诺伊州芝加哥；2011年6月3日至7日。
JOP. 2011 Jul 8;12(4):351-4.
9
Kidney Cancer Research Highlights from ASCO 2022 Annual Meeting.2022年美国临床肿瘤学会年会肾癌研究亮点
Kidney Cancer J. 2022 Jun;20(2):61-64.
10
Recent advances in lung cancer: summary of presentations from the 45th annual meeting of the American Society of Clinical Oncology (2009).近年来肺癌领域的研究进展：第 45 届美国临床肿瘤学会年会（2009 年）演讲总结。
J Thorac Oncol. 2009 Oct;4(10):1293-300. doi: 10.1097/JTO.0b013e3181b7ef95.

引用本文的文献

1
Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model.使用基于混合代理的模型来研究局部吉西他滨治疗胰腺癌的疗效。
PLoS Comput Biol. 2023 Jan 17;19(1):e1010104. doi: 10.1371/journal.pcbi.1010104. eCollection 2023 Jan.
2
Dosimetric impact of simulated changes in large bowel content during proton therapy with simultaneous integrated boost for locally advanced pancreatic cancer.模拟局部进展期胰腺癌质子调强放疗同时整合推量时大肠内容物变化对剂量学的影响。
J Appl Clin Med Phys. 2021 Nov;22(11):90-98. doi: 10.1002/acm2.13429. Epub 2021 Oct 2.
3
Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms.自噬通过细胞自主和非自主机制维持胰腺癌生长。
Cancer Discov. 2018 Mar;8(3):276-287. doi: 10.1158/2159-8290.CD-17-0952. Epub 2018 Jan 9.
4
Clinical Practice Guidelines for Cryosurgery of Pancreatic Cancer: A Consensus Statement From the China Cooperative Group of Cryosurgery on Pancreatic Cancer, International Society of Cryosurgery, and Asian Society of Cryosurgery.《胰腺癌冷冻手术临床实践指南：中国胰腺癌冷冻手术协作组、国际冷冻外科学会和亚洲冷冻外科学会的共识声明》
Pancreas. 2017 Sep;46(8):967-972. doi: 10.1097/MPA.0000000000000878.

本文引用的文献

1
Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials.SPARC表达对未接受白蛋白结合型紫杉醇的晚期胰腺癌患者预后的影响：一项来自前瞻性临床和转化试验的汇总分析
Br J Cancer. 2016 Dec 6;115(12):1520-1529. doi: 10.1038/bjc.2016.355. Epub 2016 Nov 1.
2
Effectiveness and Tolerability of Maintenance Capecitabine Administrated to Patients with Metastatic Pancreatic Cancer Treated with First-Line FOLFIRINOX.一线FOLFIRINOX方案治疗的转移性胰腺癌患者维持使用卡培他滨的有效性和耐受性
Oncology. 2016;90(5):261-6. doi: 10.1159/000444854. Epub 2016 Apr 21.
3
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse.吉西他滨与FOLFIRINOX方案治疗hENT1阳性晚期胰腺腺癌患者：当一切看似更糟时，并非一切都那么糟糕。
Clin Transl Oncol. 2016 Oct;18(10):988-95. doi: 10.1007/s12094-015-1471-z. Epub 2016 Jan 7.
4
Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort.在Folfirinox方案治疗失败后，纳武单抗联合吉西他滨用于转移性胰腺腺癌：一项AGEO前瞻性多中心队列研究
Br J Cancer. 2015 Sep 29;113(7):989-95. doi: 10.1038/bjc.2015.328. Epub 2015 Sep 15.
5
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.一项II/III期随机研究，比较瑞戈非尼联合吉西他滨与单用吉西他滨治疗既往未治疗的转移性胰腺癌患者的疗效和安全性。
Ann Oncol. 2015 Sep;26(9):1923-1929. doi: 10.1093/annonc/mdv264. Epub 2015 Jun 19.
6
Allelic ratio of KRAS mutations in pancreatic cancer.胰腺癌中KRAS突变的等位基因比率。
Oncologist. 2015 Apr;20(4):e8-9. doi: 10.1634/theoncologist.2014-0408. Epub 2015 Mar 16.
7
A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression.一项II期、开放标签、多中心研究，旨在评估CO-1.01作为二线疗法治疗吉西他滨难治的IV期胰腺腺癌且肿瘤hENT1表达阴性患者的抗肿瘤疗效。
Pancreatology. 2014 Sep-Oct;14(5):398-402. doi: 10.1016/j.pan.2014.07.003. Epub 2014 Jul 18.
8
Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma.卡培他滨用于局部晚期不可切除胰腺腺癌患者的维持治疗。
Oncol Lett. 2014 Sep;8(3):1302-1306. doi: 10.3892/ol.2014.2238. Epub 2014 Jun 11.
9
Biomarkers in pancreatic adenocarcinoma.胰腺腺癌中的生物标志物
JOP. 2014 Jul 28;15(4):308-9. doi: 10.6092/1590-8577/2675.
10
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.白蛋白结合型紫杉醇联合吉西他滨治疗胰腺癌可提高生存率。
N Engl J Med. 2013 Oct 31;369(18):1691-703. doi: 10.1056/NEJMoa1304369. Epub 2013 Oct 16.

Recent advances in pancreatic cancer: updates and insights from the 2015 annual meeting of the American Society of Clinical Oncology.

作者信息

Abrams Matthew J, Rakszawski Kevin, Vasekar Monali, Passero Frank, Abbas Atif, Jia Yuxia, Saif Muhammad Wasif

机构信息

Tufts University School of Medicine, Boston, MA, USA.

Penn State Hershey Medical Center, Hershey, PA, USA.

出版信息

Therap Adv Gastroenterol. 2016 Mar;9(2):141-51. doi: 10.1177/1756283X15622601.

DOI:10.1177/1756283X15622601
PMID:26929776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4749860/
Abstract
摘要